Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes.

Avy A SkolnikAmanda NoskaVera YakovchenkoJack TsaiNatalie JonesAllen L GiffordD Keith McInnes

Published in: BMC health services research (2019)

Despite the improved side-effect profile of newer HCV medications, multiple barriers to treatment completion remain. However, providers and patients were able to identify avenues for addressing such barriers.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis c virus
prognostic factors
peritoneal dialysis
mental health
patient reported outcomes
human immunodeficiency virus
immune response
metabolic syndrome
skeletal muscle
weight loss
antiretroviral therapy